Recurrent HCMV Infection in Hand Transplant Recipient
Author Information
Author(s): Fausto Baldanti, Giovanna Lucchini, Daniele Lilleri, Marco Lanzetta
Primary Institution: Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Hypothesis
To what extent systemic life-threatening complications can be risked for non-life-saving transplant procedures?
Conclusion
Careful monitoring of HCMV-specific T-cell immunity is crucial in D+R- transplant recipients to avoid recurrent HCMV infections.
Supporting Evidence
- The patient lacked HCMV-specific T cell immunity for over 3 years after transplantation.
- Recovery of HCMV-specific T-cell responses was associated with the resolution of viral infection.
- Monitoring of HCMV load and T-cell responses helped avoid major complications.
Takeaway
A patient who received a hand transplant kept getting sick from a virus because his body couldn't fight it off. Doctors helped him get better by giving him medicine and watching his health closely.
Methodology
The study involved monitoring HCMV infection through antigenemia and DNAemia, and assessing T-cell responses using a novel assay.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
33-year-old HCMV-seronegative Caucasian male.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website